Latest filing published 03 Jun 2026 for Kane Biotech Inc., €124k.
Filing timeline
BuySaleInsider track record
Robert Huizinga: trading record in brief
This profile gathers the share dealings of Robert Huizinga in Kane Biotech Inc. Between 21 February 2024 and 28 May 2026, the trades on record add up to 5 filings.
The open-market record is one-sided, with 1 purchase worth €7,477 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 option exercise.
Most recently, on 3 June 2026, the filings show an option exercise worth €124k in Kane Biotech Inc. The last purchase on record was published on 17 September 2024, which is 784 days ago. Typically, a trade is published a median of 6 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.
Companies and markets linked to Robert Huizinga
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000,000 shares@ CA$0.05100.0% of flowOptionsTSXSEDI:4728297
- OptionsTSXSEDI:4728289
- 60,000 shares@ CA$0.103.2% of flowCommon SharesTSXSEDI:4440768
- Common SharesTSXSEDI:4376357
- 90,000 shares@ CA$0.12564.9% of flowCommon SharesTSXSEDI:4376359Canonical exit: 12 Dec 2024 (T+90)
5 of 5 declarations